ACXP - Acurx signals progress in Phase 3 ibezapolstat program with $12M credit line following regulatory alignment
2025-05-13 14:00:45 ET
More on Acurx Pharmaceuticals
- Acurx Pharmaceuticals, Inc. (ACXP) Q1 2025 Earnings Call Transcript
- Acurx Pharmaceuticals, Inc. (ACXP) Q4 2024 Earnings Call Transcript
- Acurx Pharmaceuticals announces resale of 8.4M shares
- Acurx Pharmaceuticals stock sinks on $1.1M direct offering
- Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals